Literature DB >> 33364037

Infected abdominal aorta aneurysm secondary to streptococcal toxic shock syndrome due to Streptococcus pyogenes: a case report from Japan.

Shiho Taniguchi1, Yukio Sato1, Naotaka Shimatani1, Yosaku Torii2, Mariko Sekimizu2, Yuki Kamiya3, Kentaro Matsubara3, Hideaki Obara3, Junichi Sasaki1.   

Abstract

BACKGROUND: Infected aortic aneurysm secondary to streptococcal toxic shock syndrome caused by Streptococcus pyogenes is uncommon and associated with high mortality. CASE
PRESENTATION: A 75-year-old man with metastatic lung cancer and an abdominal aortic aneurysm presented with high fever for 3 days. He was diagnosed with septic shock and was admitted to our hospital. The blood culture was positive for S. pyogenes, and streptococcal toxic shock syndrome was diagnosed. During treatment, enhanced computed tomography revealed an increase in the size of the abdominal aortic aneurysm, leading to the diagnosis of an infected aortic aneurysm. Replacement of the aneurysm with a synthetic graft was carried out successfully. The patient gradually recovered after the surgery.
CONCLUSION: We successfully managed an infected aortic aneurysm secondary to streptococcal toxic shock syndrome. Infected aortic aneurysms should be considered in patients with a medical history of aortic aneurysms and presenting with streptococcal toxic shock syndrome.
© 2020 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.

Entities:  

Keywords:  Cancer; Streptococcus pyogenes; group A streptococcus; infected abdominal aortic aneurysm; streptococcal toxic shock syndrome

Year:  2020        PMID: 33364037      PMCID: PMC7750026          DOI: 10.1002/ams2.617

Source DB:  PubMed          Journal:  Acute Med Surg        ISSN: 2052-8817


Introduction

Streptococcal toxic shock syndrome (STSS), caused by Streptococcus pyogenes (S. pyogenes), is associated with critical complications and mortality. Infected aortic aneurysms (IAAs), although uncommon, are also associated with severe complications and mortality. Although S. pyogenes is not a major causative pathogen of IAAs, 13 cases of S. pyogenes‐related IAAs have been reported. , , , , , , , , , , , , Herein, we report the case of a patient with an asymptomatic infected abdominal aortic aneurysm who successfully underwent aortic replacement with a bifurcated vascular prosthesis following S. pyogenes‐induced STSS.

Case

A 75‐year‐old man was transferred to our hospital by the emergency medical service with a complaint of high fever (>39.0°C) for 3 days. He had a history of metastatic lung cancer following a hypopharyngeal cancer surgery and was treated with nivolumab. He also had a 25‐mm abdominal aortic aneurysm involving the iliac bifurcation. Vital signs showed altered mental status (Glasgow Coma Scale score, 14 [E4V4M6]) and shock (heart rate, 117 b.p.m.; blood pressure, 66/47 mmHg). Physical examination revealed erythema on the left shoulder. Hypoxia and hypotension necessitated mechanical ventilation, continuous norepinephrine administration, and vasopressin infusion. Laboratory investigations revealed thrombocytopenia, elevated creatinine, coagulopathy, liver dysfunction, and abnormal serum lactate levels (Table 1). A computed tomography (CT) scan of the trunk did not show any radiological signs indicative of the cause of fever. The patient was diagnosed with septic shock and was admitted to the intensive care unit on a regime of tazobactam/piperacillin. On day 2, the blood culture was positive for group A streptococcus, prompting a diagnosis of STSS. Accordingly, the antibiotics were changed to penicillin G, clindamycin, and vancomycin. Furthermore, hydrocortisone, fludrocortisone, i.v. immunoglobulin, and thrombomodulin were also given for 6, 7, 3, and 5 days, respectively (Fig. 1). Continuous hemodiafiltration with an acrylonitrile‐co‐methallyl sulfonate surface‐treated (AN‐69ST) membrane was undertaken for 6 days. Finally, the group A streptococcus was identified as S. pyogenes; genetic analysis classified it as the emm1 strain of S. pyogenes (T serotyping, T1; M serotyping, M1; and emm typing, emm1; Spegene, speA, speB, and speC). Despite treatment, the C‐reactive protein levels did not decrease below 8 mg/dL (Fig. 1). An enhanced CT scan of the trunk on day 30 revealed that the aneurysm had increased in size since the previous CT scan and also revealed an enhanced aneurysm wall and a saccular appearance of the aneurysm, suggesting IAA (Fig. 2). In situ repair with a bifurcated expanded polytetrafluoroethylene vascular graft and omental wrapping were undertaken successfully on day 31. Intraoperatively, the tissue surrounding the aortic aneurysm was observed to be edematous and hemorrhagic and had strong adhesions. Culture of the sample collected from the aortic wall during surgery was negative. Furthermore, preoperative blood cultures on days 7, 14, and 31 were also negative. After the surgery, the patient recovered and the C‐reactive protein level gradually reverted to normal. On resolution of ventilator‐associated pneumonia, hospital‐acquired pneumonia, and pneumothorax, he was weaned off the ventilator on day 189 and walked without support from day 240.
Table 1

Laboratory findings on day 1 of admission of a 75‐year‐old man with infected abdominal aorta aneurysm secondary to streptococcal toxic shock syndrome

Arterial blood gas analysis (FiO2, 0.4)Biochemistry
pH7.480Total protein5.3g/dL
pCO2 21.0mmHgAlbumin2.6g/dL
pO2 120.0mmHgNa126.4mEq/L
HCO3 22.4mmol/LK3.9mEq/L
Anion gap15.6mmol/LCl95.0mEq/L
Lactate5.0mmol/LUN33.2mg/dL
Complete blood countCr2.04mg/dL
WBC14.6×103/µLUA7.2mg/dL
Hb12.3g/dLAST640U/L
Platelet108×103/µLALT130U/L
CoagulationLD1,889U/L
PT12.3secALP202U/L
APTT38.5secγ‐GTP32U/L
Fibrinogen578mg/dLAMY212U/L
FDP109.6µg/mLCK49,565U/L
D‐dimer71.2µg/mLCRP22.31mg/dL
EndocrineProcalcitonin88.08ng/mL
Glucose142mg/dL

γ‐GTP, γ‐glutamyl transferase; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AMY, amylase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; Cl, chloride; CK, creatine kinase; Cr, creatinine; CRP, C‐reactive protein; FDP, fibrin degradation products; Hb, hemoglobin; K, potassium; LD, lactate dehydrogenase; Na, sodium; UA, uric acid; UN, urea nitrogen; WBC, white blood cells.

Fig. 1

Clinical course of infected abdominal aorta aneurysm secondary to streptococcal toxic shock syndrome in a 75‐year‐old man, with C‐reactive protein levels (CRP) and treatment. AVP, vasopressin; CHDF, continuous hemodiafiltration; CLDM, clindamycin; FC, fludrocortisone; HC, hydrocortisone; IVIG, i.v. immunoglobulin; NAD, noradrenaline; PCG, penicillin G; PIPC, piperacillin; TAZ, tazobactam; TM, thrombomodulin; VCM, vancomycin.

Fig. 2

Enhanced computed tomography images of an infected abdominal aorta aneurysm secondary to streptococcal toxic shock syndrome in a 75‐year‐old man. Images show the aortic aneurysm on day 2 (A) and day 30 (B–D). Arrows (B,D) indicate the increased size of the aneurysm compared to the size noted in the previous computed tomography examination. Arrowheads (C) indicate the enhanced aneurysm wall and saccular appearance of the aneurysm.

Laboratory findings on day 1 of admission of a 75‐year‐old man with infected abdominal aorta aneurysm secondary to streptococcal toxic shock syndrome γ‐GTP, γ‐glutamyl transferase; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AMY, amylase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; Cl, chloride; CK, creatine kinase; Cr, creatinine; CRP, C‐reactive protein; FDP, fibrin degradation products; Hb, hemoglobin; K, potassium; LD, lactate dehydrogenase; Na, sodium; UA, uric acid; UN, urea nitrogen; WBC, white blood cells. Clinical course of infected abdominal aorta aneurysm secondary to streptococcal toxic shock syndrome in a 75‐year‐old man, with C‐reactive protein levels (CRP) and treatment. AVP, vasopressin; CHDF, continuous hemodiafiltration; CLDM, clindamycin; FC, fludrocortisone; HC, hydrocortisone; IVIG, i.v. immunoglobulin; NAD, noradrenaline; PCG, penicillin G; PIPC, piperacillin; TAZ, tazobactam; TM, thrombomodulin; VCM, vancomycin. Enhanced computed tomography images of an infected abdominal aorta aneurysm secondary to streptococcal toxic shock syndrome in a 75‐year‐old man. Images show the aortic aneurysm on day 2 (A) and day 30 (B–D). Arrows (B,D) indicate the increased size of the aneurysm compared to the size noted in the previous computed tomography examination. Arrowheads (C) indicate the enhanced aneurysm wall and saccular appearance of the aneurysm.

Discussion

We successfully managed this case of an IAA related to STSS. Both conditions have high mortality rates. In accordance with the existing definition, STSS was diagnosed on the basis of the presence of hypotension, elevated creatinine levels, thrombocytopenia, and skin rashes. The major causes of STSS are viral infections, pharyngitis, or soft tissue infections; however, these were not evident in our case. Regarding the diagnosis of IAAs, aneurysms with sterile cultures are diagnosed as IAAs only if they appear typically eccentric and perforated or penetrated during the surgery and if patients show signs of infection requiring antibiotic therapy before surgery. Among the previously reported 13 cases of IAA due to S. pyogenes, six cases reported specimen culture results, and five of these were positive (Table 2). Although we had no pathological evidence that suggested that the expanding aortic aneurysm was due to an S. pyogenes infection, the CT and intraoperative findings were compatible with those of an infected abdominal aorta aneurysm secondary to an S. pyogenes infection.
Table 2

Previously published cases of infected aortic aneurysm by Streptococcus pyogenes

CaseFirst authorYear of publicationAge/sexSite of aneurysmSurgical treatment

Medical treatment

(empiric → directed)

Outcome S. pyogenes in culture
BloodAneurysm wallOther
1Valero199265/MInfrarenal abdResection with bypass graft (1HD)ABPC/SBT, AZT → NFPC, PCGDead (2HD)++Throat swab +
2Sing199458/FInfrarenal abdGraftN/DSurvivedN/DThrombus in aneurysm +
3Bisognano199736/MSubclavianRepair with graft (2HD)N/DDead (8HD)++N/D
4Barth20001.5/FAscendingResection with graft (8HD)CXM, GM → PCGSurvived+N/DPericardial effusion +
5Chen200881/MAbdNoneN/DDead (1HD)+N/DN/D
6Leiva200963/FThorac‐abdResection with bypass graftVCM, IPM → PCGSurvivedN/DN/DN/D
7Vallejo201163/FThorac‐abdResection with graftVCM, IPM → PCG, DBECPCGSurvivedN/DN/DN/D
8Hoffman20122/MDescendingRepair with graft (3HD)CTRX, ABPC/SBT → CLDM, ABPCSurvived++N/D
9Gardiner201360/MInfrarenal abdEVAR and bypassVCM, CTRX, MNZ → DBECPCG, PIPC/TAZ, AMPC/CVASurvived+N/DPeriaortic mass +
10Biswas201358/MCIA bifBypass with graftAMPC/CVASurvivedN/D+N/D
11Tamenishi201363/MArch and abdBypass (15HD) and resection (22HD)AMPC, CLDMSurvived+N/DN/D
12Cherbanyk201769/FInfrarenal abdResection with graftPIPC/TAZ → CTRX, CLDMSurvive+N/D
13Someili201970/MArchEVARCEZ → PCGSurvive+N/DN/D
14Taniguchi202075/MAbdGraftPIPC/TAZ, VCM, CLDM → PCGSurvive+Sputum +

−, negative; +, positive; Abd, abdominal aorta; ABPC, ampicillin; AMPC, amoxicillin; Arch, arch aorta; Ascending, ascending aorta; AZT, aztreonam; CEZ, cefazolin; CIA bif, common iliac artery bifurcation; CLDM, clindamycin; CTRX, ceftriaxone; CVA, clavulanate; CXM, cefuroxime; DBECPCG, benzylpenicillin; Descending, descending thoracic aorta; EVAR, endovascular aneurysm repair; F, female; GM, gentamicin; HD, hospital day; IPM, imipenem; M, male; MNZ, metronidazole; N/D, no data; NFPC, nafcillin; PCG, penicillin G; PIPC, piperacillin; SBT, sulbactam; Subclavian, subclavian artery; TAZ, tazobactam; Thorac‐abd, thoracoabdominal aorta; VCM, vancomycin.

Previously published cases of infected aortic aneurysm by Streptococcus pyogenes Medical treatment (empiric → directed) −, negative; +, positive; Abd, abdominal aorta; ABPC, ampicillin; AMPC, amoxicillin; Arch, arch aorta; Ascending, ascending aorta; AZT, aztreonam; CEZ, cefazolin; CIA bif, common iliac artery bifurcation; CLDM, clindamycin; CTRX, ceftriaxone; CVA, clavulanate; CXM, cefuroxime; DBECPCG, benzylpenicillin; Descending, descending thoracic aorta; EVAR, endovascular aneurysm repair; F, female; GM, gentamicin; HD, hospital day; IPM, imipenem; M, male; MNZ, metronidazole; N/D, no data; NFPC, nafcillin; PCG, penicillin G; PIPC, piperacillin; SBT, sulbactam; Subclavian, subclavian artery; TAZ, tazobactam; Thorac‐abd, thoracoabdominal aorta; VCM, vancomycin. There are no standard strategies for treating IAAs. The optimal management of infected aneurysms, including the duration of the preoperative antibiotic therapy, remains unclear. To reduce the risk of fatality, we carried out the surgery immediately after the diagnosis and in situ reconstruction with a prosthetic graft and omental wrapping, as well as lifelong antibiotic therapy. The emm1 strain of S. pyogenes is the most predominant genotype in STSS. Among the previously reported 13 cases, genetic information was presented in two cases; in one case, M and T serotyping revealed M3 and T3, respectively, whereas in the other case, emm typing revealed the emm44 strain, indicating that different strains of S. pyogenes can cause IAAs. Therefore, factors contributing to its invasiveness and virulence remain unclear and warrant further investigation.

Conclusion

We successfully managed an unusual case of IAA secondary to STSS caused by the emm1 strain of S. pyogenes. Infected aortic aneurysms should be considered as differential diagnoses in cases of STSS in patients with a medical history of aortic aneurysm.

Disclosure

Approval of the research protocol: N/A. Informed consent: Informed consent was obtained from the patient. Registry and the registration no. of the study/trial: N/A. Animal studies: N/A. Conflict of interest: None.
  19 in total

1.  [Mycotic thoraco-abdominal aortic aneurysm secondary to streptococcus pyogenes: are we coming to the past?].

Authors:  Luis Leiva; Agustín Arroyo; José Porto; Ricardo Gesto
Journal:  Cir Esp       Date:  2009-02-06       Impact factor: 1.653

Review 2.  The Evaluation and Management of Toxic Shock Syndrome in the Emergency Department: A Review of the Literature.

Authors:  Michael Gottlieb; Brit Long; Alex Koyfman
Journal:  J Emerg Med       Date:  2018-01-20       Impact factor: 1.484

3.  Mycotic pseudoaneurysm of the aorta in children.

Authors:  H Barth; R Moosdorf; J Bauer; D Schranz; H Akintürk
Journal:  Pediatr Cardiol       Date:  2000 May-Jun       Impact factor: 1.655

4.  Leaking mycotic abdominal aortic aneurysm.

Authors:  T M Sing; N Young; I C O'Rourke; P Tomlinson
Journal:  Australas Radiol       Date:  1994-11

5.  Management of infected aortoiliac aneurysms.

Authors:  D J Reddy; A D Shepard; J R Evans; D J Wright; R F Smith; C B Ernst
Journal:  Arch Surg       Date:  1991-07

6.  Extra-aortic mycotic aneurysm due to group A Streptococcus after pharyngitis.

Authors:  Jason S Biswas; Oliver T A Lyons; Rachel E Bell; Nicholas Price
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

7.  Management of the infected aortoiliac aneurysms.

Authors:  Kamphol Laohapensang; Supapong Aworn; Saranat Orrapi; Robert B Rutherford
Journal:  Ann Vasc Dis       Date:  2012

8.  Spontaneous infective spondylitis and mycotic aneurysm: incidence, risk factors, outcome and management experience.

Authors:  Shih-Hao Chen; Wei-Che Lin; Chen-Hsiang Lee; Wen-Yi Chou
Journal:  Eur Spine J       Date:  2007-11-28       Impact factor: 3.134

9.  Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012.

Authors:  T Ikebe; K Tominaga; T Shima; R Okuno; H Kubota; K Ogata; K Chiba; C Katsukawa; H Ohya; Y Tada; N Okabe; H Watanabe; M Ogawa; M Ohnishi
Journal:  Epidemiol Infect       Date:  2015-03       Impact factor: 4.434

10.  An Unusual Case of Streptococcus pyogenes Causing Ruptured Aortic Mycotic Aneurysm.

Authors:  Ali Someili; Anjali Shroff
Journal:  Case Rep Infect Dis       Date:  2019-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.